Eleonore Jarry-Ferron
Venture @ Brightspark Ventures
Montréal, Canada
Eleonore Jarry-Ferron is a seed investor at Brightspark Ventures in Montréal focused on Content and Software. Eleonore Jarry-Ferron
- Total investments:
- 4
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Eleonore Jarry-Ferron invests in
Stages Eleonore Jarry-Ferron invests in
Countries Eleonore Jarry-Ferron invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Content 1 (25%)
- Software 1 (25%)
- Analytics 1 (25%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
Stage
- Seed 3 (75%)
- Pre-Seed 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Enurgen
|
Enurgen is a modeling software for power systems. Enurgen captures and distributes energy resources from cells to systems. Their bifacial resource from front to back is a bifacial performance model that calculates optical and electrical performance based on a physically representative array geometry. | $4.1M / Seed / Oct 08, 2025 | |
DrugBank
|
DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally. | $7.1M / Seed / Apr 11, 2022 | |
Pelcro
|
Pelcro is the #1 Content Subscription Platform that has everything publishers need to sell digital content subscriptions. | $18K / Seed / Jan 31, 2018 | |
|
Pelcro
|
Pelcro is the #1 Content Subscription Platform that has everything publishers need to sell digital content subscriptions. | Pre-Seed |
Co-Investors
About Brightspark Ventures
Brightspark Ventures invests in early stage Canadian software companies.Brightspark has been investing in the Canadian VC industry since 1999. Over the last 20 years, the company has refined its focus to the point where it choose what it believes to be the best early-stage opportunities in the market. The company's goal is to findexceptional startups, and work closely with these companies as they grow to achieve stellar returns.We have structured our investments to allow individual accredited investors to invest with us. We have found that individual investors share the same goals as us when investing: they too want to invest in startups with CEOs that are focused on creating massive returns.This model also benefits our portfolio companies, who appreciate having a network of investors they don’t necessarily have to "manage". By leading the investment and actively working as the gatekeeper for the company, Brightspark ensures that the company can grow to its full potential without being distracted or becoming unfocused. This model attracts some of the best companies in Canada.
Brightspark Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Lugsdin
Partner
|
|||
|
Eleonore Jarry-Ferron
Venture
|
|||
Emilie Jones
Marketing Director
|
|||
Jacques Perreault
Senior Partner
|
|||
Mark Skapinker
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Eleonore Jarry-Ferron invest in?
Eleonore Jarry-Ferron invests primarily in Content, Software and Analytics startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Eleonore Jarry-Ferron?
Public channels for Eleonore Jarry-Ferron include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Eleonore Jarry-Ferron last invest?
The most recent investment recorded for Eleonore Jarry-Ferron closed in Oct 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
